文献速递炎症性肠病

机器学习识别新诊断儿童克罗恩病穿透性和狭窄性并发症的新型血液蛋白预测因子

Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-11-01

本研究利用儿童克罗恩病RISK起始队列的病例-队列设计,检测基线血浆92种炎症相关蛋白,用随机生存森林筛选预测B2狭窄和B3穿透并发症的蛋白标志物,并与临床变量和血清学模型比较。含5种蛋白标志物的模型预测B3的AUC为0.79,含4种蛋白标志物的模型预测B2的AUC为0.68。B2相关蛋白在回肠基质细胞高表达,B3相关蛋白在外周血和回肠T细胞显著。

要点

  • 5种蛋白标志物模型预测B3穿透并发症的AUC为0.79。
  • 4种蛋白标志物模型预测B2狭窄并发症的AUC为0.68。
  • B2相关蛋白在回肠基质细胞高表达,B3相关蛋白在外周血和回肠T细胞显著。

核心结论

  • 研究识别出分别与儿童克罗恩病B2狭窄和B3穿透并发症进展相关的 novel 血浆蛋白标志物。

研究设计与样本

  • 病例-队列研究,利用儿童克罗恩病RISK起始队列,基线均为炎症型(B1)患者。
  • 检测基线血浆92种炎症相关蛋白(Olink Proteomics邻位延伸分析法)。
  • 采用随机生存森林(RSF)机器学习方法筛选预测B2和B3并发症的变量。
  • 将筛选出的蛋白标志物与仅临床变量模型和仅血清学模型进行比较。
  • 在单细胞测序队列中分析所选蛋白在血液和回肠的差异细胞表达。

主要发现

  • 共纳入265例患者,平均年龄11.6岁(标准差3.2)。
  • 分别有73例和34例患者发生B2和B3并发症,B2平均随访1123天(标准差477),B3平均随访1251天(标准差442)。
  • 含5种蛋白标志物的模型预测B3的AUC为0.79(95%CI 0.76-0.82),血清学模型为0.69(95%CI 0.66-0.72),临床变量模型为0.74(95%CI 0.71-0.77)。
  • 含4种蛋白标志物的模型预测B2的AUC为0.68(95%CI 0.65-0.71),血清学模型为0.62(95%CI 0.59-0.65),临床变量模型为0.52(95%CI 0.50-0.55)。
  • B2相关蛋白在回肠基质细胞高表达,B3相关蛋白在外周血和回肠T细胞显著表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a need for improved risk stratification in Crohn's disease. AIM: To identify novel blood protein biomarkers associated with future Crohn's disease complications METHODS: We performed a case-cohort study utilising a paediatric inception cohort, the Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn's disease (RISK) study. All patients had inflammatory disease (B1) at baseline. Outcomes were development of stricturing (B2) or penetrating (B3) complications. We assayed 92 inflammation-related proteins in baseline plasma using a proximity extension assay (Olink Proteomics). An ensemble machine learning technique, random survival forests (RSF), selected variables predicting B2 and B3 complications. Selected analytes were compared to clinical variables and serology only models. We examined selected proteins in a single-cell sequencing cohort to analyse differential cell expression in blood and ileum. RESULTS: We included 265 patients with mean age 11.6 years (standard deviation [SD] 3.2). Seventy-three and 34 patients, respectively, had B2 and B3 complications within mean 1123 (SD 477) days for B2 and 1251 (442) for B3. A model with 5 protein markers predicted B3 complications with an area under the curve (AUC) of 0.79 (95% confidence interval [CI] 0.76-0.82) compared to 0.69 (95% CI 0.66-0.72) for serologies and 0.74 (95% CI 0.71-0.77) for clinical variables. A model with 4 protein markers predicted B2 complications with an AUC of 0.68 (95% CI 0.65-0.71) compared to 0.62 (95% CI 0.59-0.65) for serologies and 0.52 (95% CI 0.50-0.55) for clinical variables. B2 analytes were highly expressed in ileal stromal cells while B3 analytes were prominent in peripheral blood and ileal T cells. CONCLUSIONS: We identified novel blood proteomic markers, distinct for B2 and B3, associated with progression of paediatric Crohn's disease.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ungaro RC, Hu L, Ji J, et al. Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease. Aliment Pharmacol Ther. 2020. PMID: 33131065. doi:10.1111/apt.16136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。